CVS Health Reports Strong Fourth Quarter And Full Year Profit Growth For 2015; Confirms 2016 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
FBR Still Impressed with CVS Health (CVS) Following Inline Q4 Results; Affirms at 'Outperform'
February 9, 2016 2:34 PM ESTFBR & Co. reaffirms its Outperform rating and $120 price target on CVS Health (NYSE: CVS) following the retail pharmacy giant's Q4 report earlier Tuesday.
Analyst Steven Halper noted that revenue increased 11 percent and was inline with expectations, as was the company's quarterly... More
Leerink Partners Continues to View CVS Health (CVS) as a High Quality Stock - Reiterates Outperform
February 9, 2016 2:07 PM ESTLeerink Partners reiterated an Outperform rating on CVS Health (NYSE: CVS), and cut the price target to $110.00 (from $125.00), following the company's 4Q earnings report and conference call. On the call management highlighted that total specialty revenue grew +32% y/y, total gross PBM wins... More
